Catalent Pharma Solutions is a CDMO of peptides based in USA (NJ). Direct manufacturer. Founded 2007. Key products include CDMO Services, Peptide Formulation.
Listing reviewed July 2026.
Global CDMO headquartered in Somerset, New Jersey with significant peptide manufacturing capabilities. Offers CDMO services that optimize product development and supply for pharmaceuticals and biotech. Provides delivery technologies and manufacturing solutions including peptide formulation and fill-finish services.
Catalent Pharma Solutions is listed as a CDMO in the peptide supply chain, serving North America markets from USA (NJ). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.